Is hypercoagulability an issue in arterial thrombosis? Yes

Journal of Thrombosis and Haemostasis

Volumn 2, Issue 5, 2004, Pages 690-691

  Grant, P J ^a  

^a Academic Unit of Molecular Vascular Medicine   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 6; INSULIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; THROMBIN;

ARTERY THROMBOSIS; ATHEROMA; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BLOOD CLOTTING; BLOOD VESSEL INJURY; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CORRELATION ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE COURSE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERCOAGULABILITY; INSULIN RESISTANCE; NOTE; PATHOGENESIS; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RISK FACTOR; THROMBOGENESIS;

ARTERIAL OCCLUSIVE DISEASES; CORONARY VESSELS; DIABETES MELLITUS, TYPE 2; HUMANS; THROMBOPHILIA; THROMBOSIS;

EID: 13244272178     PISSN: 15387933     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2004.00745.x     Document Type: Note

References (12)

1. Lusis AJ. Atherosclerosis. Nature 2000; 407: 233-41.
2. Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L, Malmberg K. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 2002; 359: 2140-4.
3. Stern MP. Diabetes and cardiovascular disease. The 'common soil' hypothesis. Diabetes 1995; 44: 369-74.
4. Mills J, Grant PJ. Insulin resistance, haemostatic factors and cardiovascular risk. Br J Diabetes Vasc Dis 2002; 2: 19-26.
5. Grant PJ. The genetics of atherothrombotic disorders - a clinicians view. J Throm Haemost 2003; 1: 1381-90.
6. Natali A, Vichi S, Landi P, Severi S, L'Abbate A, Ferrannini E. Coronary atherosclerosis in Type II diabetes: angiographic findings and clinical outcome. Diabetologia 2000; 43: 632-41.
7. Shinozaki K, Suzuki M, Ikebuchi M, Hara Y, Harano Y. Demonstration of insulin resistance in coronary artery disease documented with angiography. Diabetes Care 1996; 19: 1-7.
8. Moreno PR, Murcia AM, Palacios IF, Leon MN, Bernardi VH, Fuster V, Fallon JT. Coronary composition and macrophage infiltration in atherectomy specimens from patients with diabetes mellitus. Circulation 2000; 102: 2180-4.
9. Butenas S, van't Veer C, Mann KG. 'Normal' thrombin generation. Blood 1999; 94: 2169-78.
10. Ariëns RAS, de Lange M, Snieder H, Boothby M, Spector TD, Grant PJ. Activation markers of coagulation and fibrinolysis in twins: heritability of the pre-thrombotic state. Lancet 2002; 359: 667-71.
11. Sambola A, Osende J, Hathcock J, Degen M, Nemerson Y, Fuster V, Crandall J, Badimon JJ. Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity. Circulation 2003; 107: 973-7.
12. Osende JI, Badimon JJ, Fuster V, Herson P, Rabito P, Vidhun R, Zaman A, Rodriguez OJ, Lev EI, Rauch U, Heflt G, Fallon JT, Crandall JP. Blood thrombogenicity in Type 2 diabetes mellitus patients is associated with glycaemic control. J Am Coll Cardiol 2001; 38 1307-12.